See more : PT Bank OCBC NISP Tbk (NISP.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Magellan Health, Inc. (MGLN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Magellan Health, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- Calima Energy Limited (CE1.AX) Income Statement Analysis – Financial Results
- Reliance Worldwide Corporation Limited (RLLWF) Income Statement Analysis – Financial Results
- AEON Credit Service (Asia) Company Limited (0900.HK) Income Statement Analysis – Financial Results
- Control Bionics Limited (CBL.AX) Income Statement Analysis – Financial Results
- Inception Growth Acquisition Limited (IGTAR) Income Statement Analysis – Financial Results
Magellan Health, Inc. (MGLN)
About Magellan Health, Inc.
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.58B | 7.16B | 7.31B | 5.84B | 4.84B | 4.60B | 3.76B | 3.55B | 3.21B | 2.80B | 2.97B | 2.64B | 2.63B | 2.16B | 1.69B | 1.81B | 1.80B | 1.51B | 445.89M | 1.76B | 1.87B | 1.87B | 1.51B | 1.21B | 1.35B | 1.15B | 904.65M |
| Cost of Revenue | 4.46B | 6.93B | 7.12B | 5.57B | 4.58B | 4.42B | 3.55B | 3.31B | 2.96B | 2.02B | 2.13B | 2.43B | 2.44B | 1.96B | 1.51B | 1.57B | 0.00 | 1.32B | 0.00 | 1.56B | 1.65B | 1.66B | 1.29B | 978.51M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 118.79M | 229.29M | 197.18M | 271.02M | 258.94M | 178.38M | 215.08M | 238.19M | 249.58M | 782.64M | 842.63M | 207.46M | 186.87M | 193.26M | 181.90M | 241.62M | 1.80B | 185.86M | 445.89M | 198.47M | 220.97M | 208.01M | 217.97M | 232.18M | 1.35B | 1.15B | 904.65M |
| Gross Profit Ratio | 2.60% | 3.20% | 2.70% | 4.64% | 5.35% | 3.88% | 5.72% | 6.72% | 7.78% | 27.96% | 28.38% | 7.85% | 7.12% | 8.96% | 10.76% | 13.36% | 100.00% | 12.30% | 100.00% | 11.31% | 11.79% | 11.11% | 14.41% | 19.18% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 876.61M | 822.39M | 723.50M | 619.55M | 557.51M | 529.63M | 566.58M | 0.00 | 0.00 | 0.00 | 0.00 | 15.81M | 1.59B | 0.00 | 391.43M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 98.39M | 131.51M | 132.66M | 115.71M | -770.57M | -719.55M | -632.43M | -547.55M | -497.02M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 358.06M | 14.38M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
| Operating Expenses | 98.39M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 588.26M | 621.26M | 47.27M | 60.81M | 57.52M | 48.86M | 64.90M | 1.63B | 358.06M | 405.81M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
| Cost & Expenses | 4.56B | 7.06B | 7.25B | 5.68B | 4.68B | 4.52B | 3.64B | 3.38B | 3.02B | 2.61B | 2.75B | 2.48B | 2.50B | 2.02B | 1.56B | 1.63B | 1.63B | 1.68B | 405.81M | 1.59B | 1.74B | 1.73B | 1.40B | 1.14B | 1.23B | 1.15B | 922.79M |
| Interest Income | 4.05M | 19.19M | 14.07M | 5.89M | 2.82M | 2.17M | 1.30M | 1.99M | 2.02M | 2.78M | 3.28M | 6.25M | 17.03M | 23.84M | 17.63M | 17.46M | 6.13M | 2.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 30.87M | 36.15M | 35.40M | 25.98M | 10.19M | 6.58M | 7.39M | 3.00M | 2.25M | 2.50M | 2.23M | 2.42M | 2.85M | 6.39M | 7.29M | 44.01M | 37.12M | 61.02M | 873.00K | -8.80M | -83.00M | -18.41M | -38.31M | -14.36M | -6.16M | 0.00 | -12.62M |
| Depreciation & Amortization | 118.75M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 48.05M | 14.38M | 70.28M | 79.24M | 73.53M | 54.89M | 44.86M | 48.92M | 64.09M | 59.55M |
| EBITDA | 487.41M | 248.48M | 211.25M | 276.97M | 263.85M | 183.25M | 221.55M | 240.18M | 251.60M | 255.79M | 279.32M | 213.70M | 203.90M | 216.74M | 205.11M | 306.09M | 214.57M | 594.65M | 29.24M | 131.22M | 28.91M | 105.60M | 55.64M | 53.60M | 107.00M | 9.82M | -10.60M |
| EBITDA Ratio | 10.65% | 3.47% | 2.89% | 4.74% | 5.45% | 3.99% | 5.89% | 6.77% | 7.84% | 9.14% | 9.41% | 8.09% | 7.77% | 10.05% | 12.13% | 16.93% | 11.95% | 39.36% | 6.56% | 7.47% | 1.54% | 5.64% | 3.68% | 4.43% | 7.95% | 0.85% | -1.17% |
| Operating Income | 368.67M | 116.97M | 78.59M | 161.27M | 157.80M | 80.40M | 130.48M | 168.19M | 191.11M | 197.16M | 224.64M | 166.43M | 143.09M | 159.21M | 156.25M | 257.00M | 172.08M | 546.60M | 14.86M | 60.94M | -50.33M | 32.06M | 750.00K | 8.74M | 58.08M | -54.27M | -70.16M |
| Operating Income Ratio | 8.05% | 1.63% | 1.07% | 2.76% | 3.26% | 1.75% | 3.47% | 4.74% | 5.96% | 7.04% | 7.57% | 6.30% | 5.45% | 7.38% | 9.24% | 14.21% | 9.58% | 36.18% | 3.33% | 3.47% | -2.69% | 1.71% | 0.05% | 0.72% | 4.32% | -4.71% | -7.75% |
| Total Other Income/Expenses | -409.15M | -36.15M | -35.40M | -26.04M | -12.28M | -9.29M | -12.56M | -3.00M | -2.25M | -2.50M | -2.23M | -2.42M | -2.85M | -6.03M | -7.33M | -45.54M | -40.54M | -60.82M | -873.00K | 8.80M | 83.00M | 18.41M | 38.31M | 14.36M | 6.16M | 0.00 | 12.62M |
| Income Before Tax | -40.49M | 80.82M | 43.19M | 135.22M | 145.52M | 71.12M | 117.92M | 165.19M | 188.87M | 194.66M | 222.40M | 164.01M | 140.24M | 153.19M | 148.92M | 211.46M | 131.54M | 485.78M | 13.99M | 69.74M | 32.67M | 50.47M | 39.06M | 23.10M | 64.24M | -54.27M | -57.54M |
| Income Before Tax Ratio | -0.88% | 1.13% | 0.59% | 2.32% | 3.01% | 1.55% | 3.14% | 4.66% | 5.89% | 6.95% | 7.49% | 6.21% | 5.34% | 7.11% | 8.81% | 11.70% | 7.33% | 32.16% | 3.14% | 3.97% | 1.74% | 2.70% | 2.58% | 1.91% | 4.78% | -4.71% | -6.36% |
| Income Tax Expense | -44.53M | 24.92M | 19.01M | 25.08M | 69.73M | 42.41M | 43.69M | 39.92M | 37.84M | 65.04M | 83.74M | 57.34M | 54.04M | 58.67M | 62.70M | 82.41M | 46.58M | 33.81M | 3.13M | 36.39M | 15.48M | 27.38M | 20.03M | 9.24M | 25.70M | -11.31M | -10.54M |
| Net Income | 4.05M | 55.90M | 24.18M | 110.14M | 75.79M | 28.71M | 74.23M | 125.26M | 151.03M | 129.62M | 138.66M | 106.67M | 86.21M | 94.52M | 86.22M | 129.05M | 84.95M | 451.97M | 10.86M | 33.35M | 17.19M | 23.10M | 19.03M | 13.86M | 38.54M | -42.96M | -47.00M |
| Net Income Ratio | 0.09% | 0.78% | 0.33% | 1.89% | 1.57% | 0.62% | 1.97% | 3.53% | 4.71% | 4.63% | 4.67% | 4.04% | 3.28% | 4.38% | 5.10% | 7.14% | 4.73% | 29.92% | 2.43% | 1.90% | 0.92% | 1.23% | 1.26% | 1.14% | 2.87% | -3.73% | -5.20% |
| EPS | 0.16 | 2.28 | 0.97 | 4.72 | 3.27 | 1.15 | 2.78 | 4.63 | 5.51 | 4.25 | 4.10 | 3.03 | 2.18 | 2.43 | 2.33 | 3.59 | 2.40 | 12.80 | 0.31 | 1.00 | 0.53 | 0.73 | 0.62 | 0.47 | 1.24 | -1.54 | -1.78 |
| EPS Diluted | 0.16 | 2.28 | 0.97 | 4.51 | 3.14 | 1.11 | 2.71 | 4.53 | 5.42 | 4.17 | 4.03 | 3.01 | 2.16 | 2.37 | 2.23 | 3.42 | 2.34 | 10.86 | 0.26 | 0.81 | 0.53 | 0.72 | 0.61 | 0.46 | 1.24 | -1.54 | -1.78 |
| Weighted Avg Shares Out | 25.78M | 24.56M | 25.04M | 23.33M | 23.18M | 24.87M | 26.69M | 27.05M | 27.39M | 30.48M | 33.78M | 35.25M | 39.61M | 38.94M | 36.99M | 35.97M | 35.37M | 35.31M | 35.14M | 33.45M | 32.14M | 31.76M | 30.78M | 29.47M | 31.01M | 27.87M | 26.39M |
| Weighted Avg Shares Out (Dil) | 25.78M | 24.56M | 25.04M | 24.44M | 24.16M | 25.88M | 27.36M | 27.68M | 27.88M | 31.06M | 34.44M | 35.42M | 40.00M | 39.84M | 38.62M | 37.69M | 36.36M | 41.61M | 41.44M | 41.24M | 32.39M | 31.92M | 31.20M | 30.17M | 31.01M | 27.87M | 26.39M |
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MGLN, FLIR, PRGX, TCP, INFO; Shareholders Are Encouraged to Contact the Firm
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Magellan Health, Inc. - MGLN
Centene (CNC) to Buy Magellan Health for Better Medical Care
Molina Healthcare (MOH) Acquires Magellan Health's Unit
ALERT: Halper Sadeh LLP Investigates MGLN, FLIR, SMTX, PRGX; Shareholders Are Encouraged to Contact the Firm
SHAREHOLDER ALERT: WeissLaw LLP Investigates Magellan Health, Inc.
MAGELLAN HEALTH ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MGLN and Encourages Investors to Contact the Firm
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Magellan Health, Inc.
What Centene Gets for Its $2.2 Billion Magellan Acquisition
Centene Is Climbing on Its Plans to Buy Magellan Health for $2.2 Billion
Source: https://incomestatements.info
Category: Stock Reports